SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052754
Filing Date
2020-11-10
Accepted
2020-11-10 08:30:32
Documents
40
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20200930.htm 10-Q 1156169
2 EX-10.1 evok-ex101_123.htm EX-10.1 152607
3 EX-31.1 evok-ex311_8.htm EX-31.1 9583
4 EX-31.2 evok-ex312_7.htm EX-31.2 9866
5 EX-32.1 evok-ex321_6.htm EX-32.1 5043
6 EX-32.2 evok-ex322_9.htm EX-32.2 5262
  Complete submission text file 0001564590-20-052754.txt   3362298

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT evok-20200930.xml EX-101.INS 512361
8 XBRL TAXONOMY EXTENSION SCHEMA evok-20200930.xsd EX-101.SCH 27483
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20200930_cal.xml EX-101.CAL 21968
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20200930_def.xml EX-101.DEF 83761
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20200930_lab.xml EX-101.LAB 207719
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20200930_pre.xml EX-101.PRE 156092
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 201299714
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences